vimarsana.com

பொருளாதார வளர்ச்சி பலகை ஆஃப் சிங்கப்பூர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trovio opens regional office in Singapore

City state seen as an important focal point for gold trading in Southeast Asia 11 May 2021 |  The Asset Trovio, a Sydney-based fintech startup that provides commodity digitization and registry services, has established a foothold in Singapore, which it considers an important focal point for gold trading in the Southeast Asian region. Aside from opening a regional office in the city state, the company also became the first fintech company to be welcomed into the Singapore Bullion Market Association (SBMA) as the gold industry looks to leverage new methods and technologies offered by digitization. According to Trovio, Singapore has already cemented its reputation as a stable financial centre and has taken steps to position itself as a bullion hub, exempting investment-grade gold, silver and platinum from a goods and services tax.

Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management

April 29, 2021 April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.   $375M: Fund for Growth-Stage Medtech, Digital Health  Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices, and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, which to date has included over USD 500 million invested in 42 companies 21 of which have exited via an acquisition or IPO. The fund has already supported seven companies with investm

Singaporean startup ImmunoScape raises $14M to advance capabilities

Singaporean startup ImmunoScape raises $14M to advance capabilities Singaporean startup ImmunoScape raises $14M to advance capabilities 19 April 2021 | News Round is co-led by EDBI, Anzu Partners and UTEC, representing major biotech innovation centers across the U.S., Singapore and Japan Image credit- shutterstock.com ImmunoScape, a Singapore headquartered biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, has announced it has completed a $14 million fundraising round led by existing investors Anzu Partners, University of Tokyo Edge Capital Partners (UTEC) and new investor EDBI, an investment arm of the Economic Development Board of Singapore. The new round brings ImmunoScape’s total funding in the past year to $25 million.

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.